Baseline renal functions predict the effect of canakinumab on regression of proteinuria in patients with familial Mediterranean fever

Introduction and objectives: Canakinumab, an IL-1 blocking drug, decreases the frequency and severity of the attacks and decreases the proteinuria level in colchicine resistant/intolerant familial Mediterranean fever (FMF) patients. However, it is not known whether patients with impaired or preserve...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tolga Yildirim, Rahmi Yilmaz, Arzu Saglam, Muge Uzerk-Kibar, Jabrayil Jabrayilov, Yunus Erdem
Formato: article
Lenguaje:ES
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/554612b4b76f4a9d905e4f81cb25abd2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!